LTRN

Lantern Pharma Inc.

Price

$2.16

return (12m)

-46.80%

p/e

-1.36

p/bv

-7.86

DIVIDEND YIELD

0.00%

LTRN price

Lantern Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LTRN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.10%

3 months

-39.33%

1 year

-46.80%

2 years

-48.08%

5 years

-84.64%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LTRN

Valuation

P/E

-1.36

Sector -4.26

Industry -4.26

P/BV

-7.86

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

2.94

Sector 1.25

Industry 1.25

P/Net Current Assets

-7.54

Sector -5.47

Industry -5.47

P/Working Capital

6.12

Sector -1.10

Industry -1.10

EPS

-1.55

Sector -1.94

Industry -1.94

BVPS

-0.27

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

579.19%

Sector -61.50%

Industry -61.50%

ROA

-216.86%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.96

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-0.37

Sector 0.43

Industry 0.43

Liabilities/Assets

1.37

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

8.58%

Sector -

Industry -

Fundamentals LTRN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LTRN Lantern Pharma Inc.	$2.16	-46.67%	0.00%	-1.36	-7.86	579.19%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LTRN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Lantern Pharma

Lantern Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2020

Time since IPO - 6 years

15

Employees

Lantern Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $25.32 million, with shareholders equity totaling $-3.22 million.

The company employs approximately 15 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Lantern Pharma Inc. reported $- in revenue, generating net income of $-18.65 million.

Key financial metrics include a P/E ratio of -1.36, a price-to-book (P/B) ratio of -7.86, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LTRN.

Market cap

$25.32 million

Net worth

$-3.22 million

$-3,220,000.00

Assets

$8.60 million

$8,600,000.00

Total Shares Outstanding

12.00 million

12,000,000

Average Daily Trading Volume

$136.70 Thousand

$136,701.48

Sector

Health Care

Industry

Biotechnology

LTRN

LTRN revenue and profits

Financial Results LTRN

DRAG THE FRAME TO SEE MORE DATA

LTRN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Lantern Pharma (LTRN) today?

A cotação de Lantern Pharma (LTRN) hoje está em US$ 2.16, com uma variação de -46.8% em relação ao último ano. A cotação de Lantern Pharma (LTRN) iniciou o ano negociando na casa dos US$ 3.03 e hoje está em US$ 2.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Lantern Pharma (LTRN) e dados de ações do Ibovespa e mercados internacionais.

Quando Lantern Pharma (LTRN) paga dividendos?

Lantern Pharma (LTRN) não distribuiu dividendos no último ano.

Is Lantern Pharma (LTRN) a good investment?

Atualmente, Lantern Pharma (LTRN) está cotada a US$ 2.16, com um P/L de -1.36, representando um desvio de -253% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -46.8 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -46.80%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Lantern Pharma (LTRN) stock?

Investir em ações de Lantern Pharma (LTRN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Lantern Pharma (LTRN) yield today?

A rentabilidade de Lantern Pharma (LTRN) foi de -19.10% no último mês, -46.80% no último ano e -84.64% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Lantern Pharma (LTRN) hoje, o investimento total seria de US$ 216.00, com base na cotação atual de US$ 2.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 114.91
Em 5 anos: US$ 33.18
Em 10 anos: US$ 216.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LTRN

Lantern Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LTRN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LTRN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Lantern Pharma

Lantern Pharma Inc.

United States

13 years

2020

15

PROFIT X PRICE LTRN

Financial Results LTRN

LTRN cash flow

Asset, Revenue and Profit Growth - LTRN

LTRN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions